Compounding Chemotherapy Market Report

China Compounding Chemotherapy Industry Market Research Report 2023-2029

  • POSTDATE：Oct 15, 2023
  • PAGES：197
  • REPORT CODE：GMM1858481
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Compounding Chemotherapy industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Omnicell

    • The Metrix Company

    • Added Pharma

    • Grifols, SA

    • Pfizer Inc

    • Dedalus Group

    • Pharmacy

    • B Braun Melsungen Ag

    • Icon Group

    • Equashield

    • Loccioni

    • Steriline SRL

    • Baxter

    By Type:

    • Pharmaceutical Dosage Alteration (PDA)

    • Pharmaceutical Ingredient Alteration (PIA)

    • Currently Unavailable Pharmaceutical Manufacturing (CUPM)

    By Application:

    • Blood Cancer

    • Prostate Cancer

    • Gastrointestinal Cancer

    • Breast Cancer

    • Others

    • Respiratory/Lung Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Compounding Chemotherapy Market Overview 2018-2029

    • 1.1 China Compounding Chemotherapy Industry Development Overview

    • 1.2 China Compounding Chemotherapy Industry Development History

    • 1.3 China Compounding Chemotherapy Industry Market Size (2018-2029)

    • 1.4 China Compounding Chemotherapy Market Analysis by Type from Production Side

      • 1.4.1 China Compounding Chemotherapy Production Volume, Production Value and Growth Rate of Pharmaceutical Dosage Alteration (PDA) (2018-2029)

      • 1.4.2 China Compounding Chemotherapy Production Volume, Production Value and Growth Rate of Pharmaceutical Ingredient Alteration (PIA) (2018-2029)

      • 1.4.3 China Compounding Chemotherapy Production Volume, Production Value and Growth Rate of Currently Unavailable Pharmaceutical Manufacturing (CUPM) (2018-2029)

    • 1.5 China Compounding Chemotherapy Market Analysis by Application from Consumption End

      • 1.5.1 China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

      • 1.5.2 China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)

      • 1.5.3 China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Gastrointestinal Cancer (2018-2029)

      • 1.5.4 China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.5 China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.6 China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Respiratory/Lung Cancer (2018-2029)

    • 1.6 China Compounding Chemotherapy Market Analysis by Region

      • 1.6.1 North China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

    Chapter 2 China Compounding Chemotherapy Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Compounding Chemotherapy Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Compounding Chemotherapy Market Status and Competition Analysis in 2023

      • 2.2.3 China Compounding Chemotherapy Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Compounding Chemotherapy Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Compounding Chemotherapy Industry Development

    Chapter 3 Compounding ChemotherapyIndustry Chain Analysis

    • 3.1 Compounding Chemotherapy Industry Chain

    • 3.2 Compounding Chemotherapy Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Compounding Chemotherapy Market

    • 3.3 Compounding Chemotherapy Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Compounding Chemotherapy Market

    Chapter 4 China Compounding Chemotherapy Market, by Type

    • 4.1 China Compounding Chemotherapy Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Compounding Chemotherapy Total Production Volume and Growth Rate from Production Side

    • 4.5 China Compounding Chemotherapy Production Volume and Growth Rate, by Type

      • 4.5.1 China Compounding Chemotherapy Production Volume and Growth Rate of Pharmaceutical Dosage Alteration (PDA)

      • 4.5.2 China Compounding Chemotherapy Production Volume and Growth Rate of Pharmaceutical Ingredient Alteration (PIA)

      • 4.5.3 China Compounding Chemotherapy Production Volume and Growth Rate of Currently Unavailable Pharmaceutical Manufacturing (CUPM)

    Chapter 5 China Compounding Chemotherapy Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Compounding Chemotherapy Total Market Size and Growth Rate from Consumption End

    • 5.5 China Compounding Chemotherapy Market Size and Growth Rate, by Application

      • 5.5.1 China Compounding Chemotherapy Market Size and Growth Rate of Blood Cancer

      • 5.5.2 China Compounding Chemotherapy Market Size and Growth Rate of Prostate Cancer

      • 5.5.3 China Compounding Chemotherapy Market Size and Growth Rate of Gastrointestinal Cancer

      • 5.5.4 China Compounding Chemotherapy Market Size and Growth Rate of Breast Cancer

      • 5.5.5 China Compounding Chemotherapy Market Size and Growth Rate of Others

      • 5.5.6 China Compounding Chemotherapy Market Size and Growth Rate of Respiratory/Lung Cancer

    Chapter 6 China Compounding Chemotherapy Market, by Region

    • 6.1 China Compounding Chemotherapy Production Volume and Production Value, by Region

    • 6.2 China Compounding Chemotherapy Sales Volume and Sales Value, by Region

    Chapter 7 North China Compounding Chemotherapy Market Analysis

    • 7.1 North China Compounding Chemotherapy Market, by Type

    • 7.2 North China Compounding Chemotherapy Market, by Application

    Chapter 8 Central China Compounding Chemotherapy Market Analysis

    • 8.1 Central China Compounding Chemotherapy Market, by Type

    • 8.2 Central China Compounding Chemotherapy Market, by Application

    Chapter 9 South China Compounding Chemotherapy Market Analysis

    • 9.1 South China Compounding Chemotherapy Market, by Type

    • 9.2 South China Compounding Chemotherapy Market, by Application

    Chapter 10 East China Compounding Chemotherapy Market Analysis

    • 10.1 East China Compounding Chemotherapy Market, by Type

    • 10.2 East China Compounding Chemotherapy Market, by Application

    Chapter 11 Northeast China Compounding Chemotherapy Market Analysis

    • 11.1 Northeast China Compounding Chemotherapy Market, by Type

    • 11.2 Northeast China Compounding Chemotherapy Market, by Application

    Chapter 12 Southwest China Compounding Chemotherapy Market Analysis

    • 12.1 Southwest China Compounding Chemotherapy Market, by Type

    • 12.2 Southwest China Compounding Chemotherapy Market, by Application

    Chapter 13 Northwest China Compounding Chemotherapy Market Analysis

    • 13.1 Northwest China Compounding Chemotherapy Market, by Type

    • 13.2 Northwest China Compounding Chemotherapy Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Omnicell

        • 14.1.1 Omnicell Company Profile

        • 14.1.2 Omnicell Compounding Chemotherapy Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 The Metrix Company

        • 14.2.1 The Metrix Company Company Profile

        • 14.2.2 The Metrix Company Compounding Chemotherapy Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Added Pharma

        • 14.3.1 Added Pharma Company Profile

        • 14.3.2 Added Pharma Compounding Chemotherapy Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Grifols, SA

        • 14.4.1 Grifols, SA Company Profile

        • 14.4.2 Grifols, SA Compounding Chemotherapy Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Pfizer Inc

        • 14.5.1 Pfizer Inc Company Profile

        • 14.5.2 Pfizer Inc Compounding Chemotherapy Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Dedalus Group

        • 14.6.1 Dedalus Group Company Profile

        • 14.6.2 Dedalus Group Compounding Chemotherapy Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pharmacy

        • 14.7.1 Pharmacy Company Profile

        • 14.7.2 Pharmacy Compounding Chemotherapy Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 B Braun Melsungen Ag

        • 14.8.1 B Braun Melsungen Ag Company Profile

        • 14.8.2 B Braun Melsungen Ag Compounding Chemotherapy Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Icon Group

        • 14.9.1 Icon Group Company Profile

        • 14.9.2 Icon Group Compounding Chemotherapy Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Equashield

        • 14.10.1 Equashield Company Profile

        • 14.10.2 Equashield Compounding Chemotherapy Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Loccioni

        • 14.11.1 Loccioni Company Profile

        • 14.11.2 Loccioni Compounding Chemotherapy Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Steriline SRL

        • 14.12.1 Steriline SRL Company Profile

        • 14.12.2 Steriline SRL Compounding Chemotherapy Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Baxter

        • 14.13.1 Baxter Company Profile

        • 14.13.2 Baxter Compounding Chemotherapy Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Compounding Chemotherapy Industry Research Conclusions

    • 15.2 Compounding Chemotherapy Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Compounding Chemotherapy Industry Market Size (2018-2029)

    • Figure China Compounding Chemotherapy Production Volume, Production Value and Growth Rate of Pharmaceutical Dosage Alteration (PDA) (2018-2029)

    • Figure China Compounding Chemotherapy Production Volume, Production Value and Growth Rate of Pharmaceutical Ingredient Alteration (PIA) (2018-2029)

    • Figure China Compounding Chemotherapy Production Volume, Production Value and Growth Rate of Currently Unavailable Pharmaceutical Manufacturing (CUPM) (2018-2029)

    • Figure China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

    • Figure China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)

    • Figure China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Gastrointestinal Cancer (2018-2029)

    • Figure China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Compounding Chemotherapy Sales Volume, Sales Value and Growth Rate of Respiratory/Lung Cancer (2018-2029)

    • Figure North China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

    • Figure Central China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

    • Figure South China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

    • Figure East China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Compounding Chemotherapy Market Size and Growth Rate from 2018-2029

    • Figure Compounding Chemotherapy Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Compounding Chemotherapy Market Share by Type in 2018

    • Figure China Compounding Chemotherapy Market Share by Type in 2023

    • Figure China Compounding Chemotherapy Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Compounding Chemotherapy Production Volume and Growth Rate of Pharmaceutical Dosage Alteration (PDA) (2018-2023)

    • Figure China Compounding Chemotherapy Production Volume and Growth Rate of Pharmaceutical Ingredient Alteration (PIA) (2018-2023)

    • Figure China Compounding Chemotherapy Production Volume and Growth Rate of Currently Unavailable Pharmaceutical Manufacturing (CUPM) (2018-2023)

    • Figure China Compounding Chemotherapy Market Share by Application in 2018

    • Figure China Compounding Chemotherapy Market Share by Application in 2023

    • Figure China Compounding Chemotherapy Total Market Size and Growth Rate from Consumption End

    • Figure China Compounding Chemotherapy Market Size and Growth Rate of Blood Cancer (2018-2023)

    • Figure China Compounding Chemotherapy Market Size and Growth Rate of Prostate Cancer (2018-2023)

    • Figure China Compounding Chemotherapy Market Size and Growth Rate of Gastrointestinal Cancer (2018-2023)

    • Figure China Compounding Chemotherapy Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Compounding Chemotherapy Market Size and Growth Rate of Others (2018-2023)

    • Figure China Compounding Chemotherapy Market Size and Growth Rate of Respiratory/Lung Cancer (2018-2023)

    • Table China Compounding Chemotherapy Production Volume by Region (2018-2023)

    • Table China Compounding Chemotherapy Production Volume Share by Region (2018-2023)

    • Figure China Compounding Chemotherapy Production Volume Share by Region (2018-2023)

    • Table China Compounding Chemotherapy Production Value by Region (2018-2023)

    • Table China Compounding Chemotherapy Production Value Share by Region (2018-2023)

    • Figure China Compounding Chemotherapy Production Value Share by Region (2018-2023)

    • Table China Compounding Chemotherapy Sales Volume by Region (2018-2023)

    • Table China Compounding Chemotherapy Sales Volume Share by Region (2018-2023)

    • Figure China Compounding Chemotherapy Sales Volume Share by Region (2018-2023)

    • Table China Compounding Chemotherapy Sales Value by Region (2018-2023)

    • Table China Compounding Chemotherapy Sales Value Share by Region (2018-2023)

    • Figure China Compounding Chemotherapy Sales Value Share by Region (2018-2023)

    • Table North China Compounding Chemotherapy Production Volume by Type (2018-2023)

    • Table North China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Figure North China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Table North China Compounding Chemotherapy Sales Volume by Application (2018-2023)

    • Table North China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Figure North China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Table Central China Compounding Chemotherapy Production Volume by Type (2018-2023)

    • Table Central China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Figure Central China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Table Central China Compounding Chemotherapy Sales Volume by Application (2018-2023)

    • Table Central China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Figure Central China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Table South China Compounding Chemotherapy Production Volume by Type (2018-2023)

    • Table South China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Figure South China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Table South China Compounding Chemotherapy Sales Volume by Application (2018-2023)

    • Table South China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Figure South China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Table East China Compounding Chemotherapy Production Volume by Type (2018-2023)

    • Table East China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Figure East China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Table East China Compounding Chemotherapy Sales Volume by Application (2018-2023)

    • Table East China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Figure East China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Table Northeast China Compounding Chemotherapy Production Volume by Type (2018-2023)

    • Table Northeast China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Figure Northeast China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Table Northeast China Compounding Chemotherapy Sales Volume by Application (2018-2023)

    • Table Northeast China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Table Southwest China Compounding Chemotherapy Production Volume by Type (2018-2023)

    • Table Southwest China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Figure Southwest China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Table Southwest China Compounding Chemotherapy Sales Volume by Application (2018-2023)

    • Table Southwest China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Table Northwest China Compounding Chemotherapy Production Volume by Type (2018-2023)

    • Table Northwest China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Figure Northwest China Compounding Chemotherapy Production Volume Share by Type (2018-2023)

    • Table Northwest China Compounding Chemotherapy Sales Volume by Application (2018-2023)

    • Table Northwest China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Compounding Chemotherapy Sales Volume Share by Application (2018-2023)

    • Table Omnicell Company Profile

    • Table Omnicell Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table The Metrix Company Company Profile

    • Table The Metrix Company Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Added Pharma Company Profile

    • Table Added Pharma Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Grifols, SA Company Profile

    • Table Grifols, SA Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Dedalus Group Company Profile

    • Table Dedalus Group Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Pharmacy Company Profile

    • Table Pharmacy Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table B Braun Melsungen Ag Company Profile

    • Table B Braun Melsungen Ag Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Icon Group Company Profile

    • Table Icon Group Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Equashield Company Profile

    • Table Equashield Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Loccioni Company Profile

    • Table Loccioni Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Steriline SRL Company Profile

    • Table Steriline SRL Compounding Chemotherapy Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Compounding Chemotherapy Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US